Company Filing History:
3 out of 16 
1 out of 832,843 Years Active: 2003-2010
Title: Fang-Jen Lee: Innovator in Viral Protein Research
Introduction
Fang-Jen Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for viral infections. With a total of four patents to his name, Lee's work is at the forefront of medical research.
Latest Patents
One of Fang-Jen Lee's latest patents focuses on a viral protein. This invention is directed to an isolated polypeptide containing SEQ ID NO: 1 or an immunogenic fragment thereof. It also includes an isolated nucleic acid encoding the polypeptide or containing a sequence at least 70% identical to SEQ ID NO: 3. Within the scope of this invention are related expression vectors, host cells, and antibodies. Additionally, the patent discloses methods of producing the polypeptide, diagnosing coronavirus infection, and identifying a test compound for treating coronavirus infection. Another notable invention relates to superoxide dismutase antibodies, methods of using them for detection, methods of testing for an inhibitor of superoxide dismutase, and methods of detecting tuberculosis infection.
Career Highlights
Fang-Jen Lee has worked with Yung Shin Pharmaceutical Industry Co., Ltd., where he has applied his expertise in biotechnology to advance medical research and product development. His innovative approaches have contributed to the understanding and treatment of various viral infections.
Collaborations
Fang-Jen Lee has collaborated with notable colleagues, including Chung-Hsiun Wu and Chia-Jung Yu. Their combined efforts have furthered research in the field and led to significant advancements in biotechnology.
Conclusion
Fang-Jen Lee is a distinguished inventor whose work in viral protein research has the potential to impact public health significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.